Korro Bio (KRRO) Return on Capital Employed (2019 - 2026)
Korro Bio (KRRO) posted Return on Capital Employed of 87.66% for Q1 2026, up 9.65% on a QoQ basis from 97.03% in Q4 2025, and down 4024.0% year-over-year from 2.23% in Q1 2025.
Korro Bio (KRRO) Return on Capital Employed (2019 - 2026) Analysis & Trends
Korro Bio's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 87.66% for Q1 2026.
- Quarterly Return on Capital Employed fell 4024.0% year-over-year to 87.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 87.66% (down 4024.0% YoY) and the FY2025 annual result came in at 77.15%, down 3318.0% from the prior year.
- Return on Capital Employed was 87.66% for Q1 2026 at Korro Bio, up from 97.03% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 41.11% in Q3 2024 and bottomed at 97.33% in Q3 2023.
- A 5-year average of 64.06% and a median of 61.34% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 5623 bps — and 2025, when it plunged 5523 bps.
- Korro Bio's Return on Capital Employed stood at 61.34% in 2022, then slipped by 20 bps to 73.81% in 2023, then soared by 43 bps to 41.79% in 2024, then plunged by 132 bps to 97.03% in 2025, then grew by 10 bps to 87.66% in 2026.
- Business Quant data shows KRRO's Return on Capital Employed at 87.66% in Q1 2026, 97.03% in Q4 2025, and 60.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -68.84% |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -87.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.66% |
| Dec 31, 2025 | -97.03% |
| Sep 30, 2025 | -60.44% |
| Jun 30, 2025 | -56.59% |
| Mar 31, 2025 | -47.42% |
| Dec 31, 2024 | -41.79% |
| Sep 30, 2024 | -41.11% |
| Jun 30, 2024 | -43.33% |
| Mar 31, 2024 | -43.22% |
| Dec 31, 2023 | -73.81% |
| Sep 30, 2023 | -97.33% |
| Jun 30, 2023 | -64.50% |
| Mar 31, 2023 | -85.12% |
| Dec 31, 2022 | -61.34% |
| Sep 30, 2022 | -70.15% |
| Jun 30, 2022 | -64.67% |
| Mar 31, 2022 | -53.44% |
| Dec 31, 2021 | -46.08% |
| Sep 30, 2021 | -36.34% |
| Jun 30, 2021 | -24.06% |